Outcomes of the major pancreatic duct stenting and high Octreotide doses administration for acute pancreatitis

Dibirov M.D.

Moscow State University of Medicine and Dentistry named after A.I. Evdokimov, City Clinical hospital named after S.I. Spasokukotskyi

Domarev L.V.

Moscow State University of Medicine and Dentistry named after A.I. Evdokimov, City Clinical hospital named after S.I. Spasokukotskyi

Shitikov E.A.

Moscow State University of Medicine and Dentistry named after A.I. Evdokimov, City Clinical hospital named after S.I. Spasokukotskyi

Isaev A.I.

Moscow State University of Medicine and Dentistry named after A.I. Evdokimov, City Clinical hospital named after S.I. Spasokukotskyi

Karsotyan G.S.

Moscow State University of Medicine and Dentistry named after A.I. Evdokimov, City Clinical hospital named after S.I. Spasokukotskyi

Khakonov M.R.

Moscow State University of Medicine and Dentistry named after A.I. Evdokimov, City Clinical hospital named after S.I. Spasokukotskyi

Outcomes of the major pancreatic duct stenting and high Octreotide doses administration for acute pancreatitis

Authors:

Dibirov M.D., Domarev L.V., Shitikov E.A., Isaev A.I., Karsotyan G.S., Khakonov M.R.

More about the authors

Journal: Endoscopic Surgery. 2016;22(4): 18‑24

DOI: 10.17116/endoskop201622418-24

Downloaded: 45

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Dibirov MD, Domarev LV, Shitikov EA, Isaev AI, Karsotyan GS, Khakonov MR. Outcomes of the major pancreatic duct stenting and high Octreotide doses administration for acute pancreatitis. Endoscopic Surgery. 2016;22(4):18‑24. (In Russ.)
https://doi.org/10.17116/endoskop201622418-24

Close metadata

Background: Destructive pancreatitis is severe surgical condition with increased lethality and high rate of complications. Materials and methods: Analysis of treatment of 210 patients with mild and severe acute destructive pancreatitis is presented. Control group included patients with standard therapy while as patients of the main group (n-156) additionally underwent endoscopic major pancreatic duct stenting and were administered with high Octreotide doses to achieve intraductal pressure decrease, prevention and treatment of internal pancreatic fistula. Results: In the main group in contrast with control group more rapid reduction of serum amylase, lipase and leukocytal intoxication index were noted. Infection developed in 11% of the main group and 20% of the control group. 3% in the main group and 9% of patients in the control group died.

Keywords:

destructive pancreatitis

diagnosis of severity

high doses of Octreotide

major pancreatic duct stenting

Authors:

Dibirov M.D.

Moscow State University of Medicine and Dentistry named after A.I. Evdokimov, City Clinical hospital named after S.I. Spasokukotskyi

Domarev L.V.

Moscow State University of Medicine and Dentistry named after A.I. Evdokimov, City Clinical hospital named after S.I. Spasokukotskyi

Shitikov E.A.

Moscow State University of Medicine and Dentistry named after A.I. Evdokimov, City Clinical hospital named after S.I. Spasokukotskyi

Isaev A.I.

Moscow State University of Medicine and Dentistry named after A.I. Evdokimov, City Clinical hospital named after S.I. Spasokukotskyi

Karsotyan G.S.

Moscow State University of Medicine and Dentistry named after A.I. Evdokimov, City Clinical hospital named after S.I. Spasokukotskyi

Khakonov M.R.

Moscow State University of Medicine and Dentistry named after A.I. Evdokimov, City Clinical hospital named after S.I. Spasokukotskyi

List of references:

Shapoval'yants S.G., Myl'nikov A.G., Orlov S.Yu. i dr. Diagnostika i lechenie ostrogo biliarnogo pankreatita. Annaly khirurgicheskoi gepatologii. 2009;14:1:29-33.
Bagnenko S.F., Gol'tsov V.R. Ostryi pankreatit — sovremennoe sostoyanie problemy i nereshennye voprosy. Al'manakh instituta khirurgii im. A.V. Vishnevskogo. 2008;3:3:104-112.
Kozarek RA, Patterson DJ, Ball TJ, Ureverse LW. Endoscopic placement of pancreatic stents and arafns in «ttve management of pancreatitis. Ann Surg. 1989;209:261-266.
Dyuzheva T.G., Dzhus E.V., Shefer A.V. i dr. Konfiguratsiya nekroza podzheludochnoi zhelezy i differentsirovannoe lechenie ostrogo pankreatita. Annaly khirurgicheskoi gepatologii. M. 2013.
Gal'perin E.I., Dyuzheva T.G. Pankreonekroz: neispol'zovannye rezervy lecheniya (Diskussionnye voprosy k kruglomu stolu). Annaly khirurgicheskoi gepatologii. 2007;12:2:46-50.
Savel'ev S., Filimonov M.I., Burnevich S.Z. Pankreonekrozy. M.: Meditsinskoi informatsionnoe agentstvo; 2008.
Kubyshkin V.A., Moroz O.V., Stepanova Yu.A. i dr. Voprosy klassifikatsii ostrogo pankreatita. Annaly khirurgicheskoi gepatologii. 2012;17:2:8.
Shabunin A.V., Bedin V.V., Shikov D.V. i dr. Rol' komp'yuternoi i magnitno-rezonansnoi tomografii v diagnostike i lechenii bol'nykh pankreonekrozom. Annaly khirurgicheskoi gepatologii. 2009;14:1:34-40.
Zatevakhin I.I., Tsitsiashvili M.Sh., Budurova M.D., Altunin A.I. Pankreonekroz (diagnostika, prognozirovanie lecheniya). Monografiya. M. 2007.
Rui Wang, Fan Yang. Haowuetall High-dose versus low-dose octreotide in the treatment of acute pancreatitis. A randomired controlled trial. Peptides. 2013;40:57-64.

Close metadata